Multiply-primed rolling-circle amplification (MPRCA) of PCV2 genomes: applications on detection, sequencing and virus

Diogenes Dezen1, Franciscus Antonius Maria Rijsewijk, Thais Fumaco Teixeira

  • 1Laboratório de Virologia, FEPAGRO Saúde Animal, Instituto de Pesquisas Veterinárias Desidério Finamor (IPVDF), Caixa Postal 47, Eldorado do Sul, 92990-000 RS, Brazil. ddezen@gmail.com

Insights

Multiply-primed rolling-circle amplification (MPRCA) effectively amplifies porcine circovirus type 2 (PCV2) genomes for sequencing and virus isolation. This method enables the creation of infectious PCV2 clones from amplified DNA, though it

Area of Science:

  • Veterinary Virology
  • Molecular Biology
  • Animal Pathology

Background:

  • Porcine circovirus type 2 (PCV2) causes post-weaning multisystemic wasting syndrome (PMWS) in pigs.
  • Accurate amplification and characterization of PCV2 genomes are crucial for understanding and controlling the disease.

Purpose of the Study:

  • To evaluate multiply-primed rolling-circle amplification (MPRCA) for amplifying PCV2 genomes.
  • To assess the utility of MPRCA-amplified PCV2 for sequencing, virus isolation, and infectious clone construction.

Main Methods:

  • MPRCA was employed to amplify PCV2 genomes from infected pig tissues.
  • Amplified genomes were cloned into plasmids, sequenced, and compared to existing isolates.
  • Recircularized cloned genomes were transfected into PK-15 cells to produce infectious virus.

Main Results:

  • MPRCA successfully amplified PCV2 genomes with high nucleotide similarity to other isolates (93-99%).
  • Sequenced PCV2 genomes were nearly identical, with only one silent substitution in the ORF2 region.
  • Transfection of recircularized MPRCA-amplified genomes yielded infectious PCV2 up to 10(5.55) TCID(50)/mL.

Conclusions:

  • MPRCA is a valuable tool for PCV2 genome amplification, facilitating sequencing and infectious clone creation.
  • The method allows straightforward construction of infectious PCV2 clones from amplified viral DNA.
  • MPRCA demonstrated lower sensitivity compared to PCR for diagnostic applications.